Delivery of HFA and CFC salbutamol from spacer devices used in infancy

International Journal of Pharmaceutics

Volumn 222, Issue 1, 2001, Pages 101-108

  Dubus, Jean Christophe ^a   Rhem, Rodney ^b   Dolovich, Myrna ^b  

^a TIMONE HOSPITAL   (France)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Chlorofluorocarbon; Hydrofluoroalkane; Inhaled therapy; Pressurized metered dose inhaler; Salbutamol; Spacer devices

Indexed keywords

CHLOROFLUOROCARBON; EOLENE; FLUORINATED HYDROCARBON; SALBUTAMOL; SALBUTAMOL SULFATE; SPREOR;

ARTICLE; COMPARATIVE STUDY; DEVICE; DRUG DELIVERY SYSTEM; IN VITRO STUDY; INFANCY; METERED DOSE INHALER; PRIORITY JOURNAL; SIMULATION; SPACER;

ALBUTEROL; ANALYSIS OF VARIANCE; BRONCHODILATOR AGENTS; CHILD; HUMANS; INFANT EQUIPMENT; INFANT, NEWBORN; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 0035800247     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00702-5     Document Type: Article

References (31)

1. Choosing the metered-dose inhalers spacer or holding chamber that matches the patient's need: Evidence that the specific drug being delivered is an important consideration
2. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children
3. Inhalational drug delivery from seven different spacer devices
4. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices
5. Optimum use of a spacer device
6. Clinical reality of the world's first CFC-free MDI
7. Standards for bioequivalence of inhaled products
8. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device
9. Bioequivalence of inhaled drugs
10. A comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler
11. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma
12. Influence of inhalation technique on response and compliance
13. Aerosol delivery to children: What to use, how to choose
14. In vitro comparison of beclomethasone and salbutamol MDI aerosols inhaled during pediatric tidal breathing from four valved holding chambers
15. In vitro comparison of salbutamol hydrofluoroalkane (Airomir) metered dose inhaler aerosols inhaled during pediatric tidal breathing from five valved holding chambers
16. Relative bioavailability of salbutamol to the lung following inhalation using metered-dose inhalation methods and spacer devices
17. Achieving the change: Challenges and successes in the formulation of CFC-free MDIs
18. Metered dose inhaler and nebuliser in acute asthma
19. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler®) and small volume antistatic metal spacer (Airomir® CFC-free MDI plus Nebuchamber®)
20. Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer
21. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices
22. Transition to CFC-free metered dose inhalers - Into the new millenium
23. Randomised trial spacer v nebuliser for acute asthma
24. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery
25. Comparison of acute bronchodilatation effects of two preparations of salbutamol aerosol in asthma
26. Technological development of Airomir (salbutamol sulphate in CFC-free system) MDI
27. Third international pediatric consensus statement on the management of childhood asthma
28. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants
29. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol
30. Aerosol delivery to wheezy infants: A comparison between a nebulizer and two small volume spacers
31. Salbutamol delivery from hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: An in vitro study